| Title | A trial of integrated buprenorphine/naloxone and HIV clinical care. |
| Publication Type | Journal Article |
| Year of Publication | 2006 |
| Authors | Sullivan, Lynn E., Declan Barry, Brent A. Moore, Marek C. Chawarski, Jeanette M. Tetrault, Michael V. Pantalon, Patrick G. O'Connor, Richard S. Schottenfeld, and David A. Fiellin |
| Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| Volume | 43 Suppl 4 |
| Pagination | S184-90 |
| Date Published | 2006 Dec 15 |
| ISSN | 1537-6591 |
| Keywords | Administration, Sublingual, Adult, Antiretroviral Therapy, Highly Active, Buprenorphine, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Follow-Up Studies, HIV Infections, Humans, Male, Middle Aged, Naloxone, Narcotic Antagonists, Opioid-Related Disorders, Pilot Projects, Probability, Reference Values, Risk Factors, Treatment Outcome |
| Abstract | Untreated opioid dependence adversely affects the care of human immunodeficiency virus (HIV)-positive patients. Buprenorphine, a partial opioid agonist, is available for maintenance treatment of opioid dependence in HIV specialty settings. We investigated the feasibility and efficacy of integrating buprenorphine, along with 2 levels of counseling, into HIV clinical care. |
| DOI | 10.1111/j.1475-6773.2011.01335.x |
| Alternate Journal | Clin. Infect. Dis. |
